Seeing Is Believing
Healthcare - Sector
IMVT is currently covered by 10 analysts with an average price target of $43.55. This is a potential upside of $14.94 (5.99%) from yesterday's end of day stock price of $41.09.
Immunovant 's activity chart (see below) currently has 99 price targets and 110 ratings on display. The stock rating distribution of IMVT is 31.58% HOLD and 68.42% BUY.
Analysts average stock forecasts to be materialized ratio is 49.94% with an average time for these price targets to be met of 170.33 days.
Highest price target for IMVT is $62, Lowest price target is $28, average price target is $43.55.
Most recent stock forecast was given by SAMANTHA SEMENKOW from CITI on 30-Jun-2026. First documented stock forecast 07-Jan-2020.
Currently out of the existing stock ratings of IMVT, 6 are a HOLD (31.58%), 13 are a BUY (68.42%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Aug-2023
$61
$22.21 (57.26%)
$58
10 days ago
(30-Jun-2026)
1/6 (16.67%)
$22.47 (58.32%)
46
Buy Since 23-May-2023
$62
$23.15 (59.59%)
$44
1 months 14 days ago
(26-May-2026)
3/10 (30%)
$28.17 (83.27%)
119
Hold Since 14-Oct-2025
$30
$-8.85 (-22.78%)
$22
1 months 18 days ago
(22-May-2026)
4/6 (66.67%)
$-4.15 (-12.15%)
431
Buy Since 23-May-2023
$43
$4.15 (10.68%)
$30
1 months 19 days ago
(21-May-2026)
3/4 (75%)
$8.87 (25.99%)
278
Buy Since 29-Jul-2020
$40
$1.15 (2.96%)
$35
1 months 19 days ago
(21-May-2026)
15/25 (60%)
$5.87 (17.20%)
271
What is IMVT (Immunovant ) average time for price targets to be met?
Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?
Which analyst has the most public recommendations on IMVT (Immunovant )?
Which analyst is the currently most bullish on IMVT (Immunovant )?
Which analyst is the currently most reserved on IMVT (Immunovant )?